Cytological Reporting on Lung FNA and Small Biopsy Specimens in the Era of Personalized Medicine

Cancer cytopathology - United States
doi 10.1002/cncy.21793
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Biobanking Metastases and Biopsy Specimens for Personalized Medicine

Journal of Biorepository Science for Applied Medicine
2015English

Observer Variability in Histopathological Reporting of Non-Small Cell Lung Carcinoma on Bronchial Biopsy Specimens

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
1996English

EGFR-gene Analysis on Cytological Specimens of Non-Small-Cell Lung Cancers

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2007English

Detection of ROS1-positive Non-Small Cell Lung Cancer on Cytological Specimens Using Immunocytochemistry

Cancer cytopathology
Cancer ResearchOncology
2018English

New Era of Personalized Medicine

Oncologist
Cancer ResearchMedicineOncology
1999English

The Importance of a Satisfactory Biopsy for the Diagnosis of Lung Cancer in the Era of Personalized Treatment

Current Oncology
Oncology
2012English

Cancer of Unknown Primary: Ancillary Testing of Cytologic and Small Biopsy Specimens in the Era of Targeted Therapy

Cancer cytopathology
Cancer ResearchOncology
2018English

Personalized Cancer Medicine: Era of Promise and Progress

Nature Reviews Clinical Oncology
Oncology
2011English

Metastatic Melanoma Moves On: Translational Science in the Era of Personalized Medicine

Cancer and Metastasis Reviews
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy